Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and Adrenogenital Syndrome

17-alpha-hydroxyprogesterone has been researched along with Adrenogenital Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertini, ES; Biagini, G; Cusmai, R; Gecz, J; Giannone, G; Lucchi, C; Rustichelli, C; Specchio, N; Terracciano, A; Trivisano, M; Ubertini, GM; Vigevano, F1
Bekman, NI; Laricheva, SIu; Osin, NS; Pomelova, VG1
Claahsen-van der Grinten, HL; Hoefsloot, LH1

Reviews

1 review(s) available for 17-alpha-hydroxyprogesterone and Adrenogenital Syndrome

ArticleYear
[From gene to disease: adrenogenital syndrome and the CYP21A2 gene].
    Nederlands tijdschrift voor geneeskunde, 2007, May-26, Volume: 151, Issue:21

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenogenital Syndrome; Androstenedione; Female; Humans; Male; Mutation; Steroid 21-Hydroxylase

2007

Other Studies

2 other study(ies) available for 17-alpha-hydroxyprogesterone and Adrenogenital Syndrome

ArticleYear
Reduced steroidogenesis in patients with PCDH19-female limited epilepsy.
    Epilepsia, 2017, Volume: 58, Issue:6

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Adrenogenital Syndrome; Cadherins; Case-Control Studies; Child; Child, Preschool; DNA Mutational Analysis; Epilepsy; Estradiol; Female; Genetic Diseases, X-Linked; Gonadal Steroid Hormones; Humans; Hydrocortisone; Intellectual Disability; Pregnanolone; Pregnenolone; Progesterone; Prospective Studies; Protocadherins; Puberty, Precocious; Reference Values

2017
[Lanthanide fluorescence immunoassay of 17alpha-hydroxyprogesterone in dried blood samples for neonatal screening for adrenogenital syndrome].
    Klinicheskaia laboratornaia diagnostika, 2010, Issue:12

    Topics: 17-alpha-Hydroxyprogesterone; Adrenogenital Syndrome; Europium; Female; Fluorescence; Humans; Immunosorbent Techniques; Infant, Newborn; Luminescent Agents; Male; Mass Screening; Sensitivity and Specificity

2010